Citadel Advisors’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-8,189
| Closed | -$81.6K | – | 14043 |
|
|
2025
Q4 | $68.3K | Buy |
+8,189
| New | +$82.6K | ﹤0.01% | 11884 |
|
|
2025
Q1 | – | Sell |
-1,104
| Closed | -$20K | – | 15413 |
|
|
2024
Q4 | $22.5K | Sell |
1,104
-1,238
| -53% | -$36.1K | ﹤0.01% | 13101 |
|
|
2024
Q3 | $93K | Sell |
2,342
-8,041
| -77% | -$216K | ﹤0.01% | 11223 |
|
|
2024
Q2 | $183K | Buy |
10,383
+4,683
| +82% | +$79.2K | ﹤0.01% | 10070 |
|
|
2024
Q1 | $94.6K | Buy |
5,700
+3,316
| +139% | +$48.2K | ﹤0.01% | 11436 |
|
|
2023
Q4 | $45.1K | Buy |
+2,384
| New | +$44.8K | ﹤0.01% | 11891 |
|
|
2023
Q3 | – | Sell |
-4,073
| Closed | -$124K | – | 14986 |
|
|
2023
Q2 | $222K | Buy |
4,073
+1,285
| +46% | +$39.5K | ﹤0.01% | 9652 |
|
|
2023
Q1 | $50.5K | Buy |
2,788
+67
| +2% | +$1.15K | ﹤0.01% | 12129 |
|
|
2022
Q4 | $27.6K | Buy |
+2,721
| New | +$29.1K | ﹤0.01% | 12828 |
|
|
2022
Q3 | – | Sell |
-1,532
| Closed | -$20K | – | 13464 |
|
|
2022
Q2 | $20K | Buy |
1,532
+1,357
| +775% | +$35.9K | ﹤0.01% | 12408 |
|
|
2022
Q1 | $9K | Sell |
175
-196
| -53% | -$8.3K | ﹤0.01% | 13388 |
|
|
2021
Q4 | $17K | Sell |
371
-1,494
| -80% | -$80K | ﹤0.01% | 13604 |
|
|
2021
Q3 | $122K | Buy |
1,865
+1,091
| +141% | +$82.8K | ﹤0.01% | 12623 |
|
|
2021
Q2 | $77K | Buy |
774
+480
| +163% | +$49.5K | ﹤0.01% | 13105 |
|
|
2021
Q1 | $37K | Sell |
294
-1,541
| -84% | -$228K | ﹤0.01% | 12995 |
|
|
2020
Q4 | $204K | Buy |
1,835
+1,445
| +371% | +$162K | ﹤0.01% | 9711 |
|
|
2020
Q3 | $46K | Sell |
390
-872
| -69% | -$151K | ﹤0.01% | 9635 |
|
|
2020
Q2 | $270K | Buy |
1,262
+107
| +9% | +$25.3K | ﹤0.01% | 8072 |
|
|
2020
Q1 | $261K | Buy |
1,155
+896
| +346% | +$255K | ﹤0.01% | 7560 |
|
|
2019
Q4 | $69K | Buy |
259
+8
| +3% | +$2.01K | ﹤0.01% | 8675 |
|
|
2019
Q3 | $76K | Sell |
251
-1,865
| -88% | -$573K | ﹤0.01% | 8593 |
|
|
2019
Q2 | $701K | Buy |
+2,116
| New | +$1.07M | ﹤0.01% | 6279 |
|
|
2019
Q1 | – | Sell |
-766
| Closed | -$349K | – | 9773 |
|
|
2018
Q4 | $190K | Buy |
766
+347
| +83% | +$138K | ﹤0.01% | 7902 |
|
|
2018
Q3 | $195K | Sell |
419
-29
| -6% | -$14K | ﹤0.01% | 8230 |
|
|
2018
Q2 | $243K | Buy |
+448
| New | +$269K | ﹤0.01% | 7569 |
|
|
2017
Q4 | – | Sell |
-118
| Closed | -$83.1K | – | 8365 |
|
|
2017
Q3 | $112K | Sell |
118
-647
| -85% | -$495K | ﹤0.01% | 6998 |
|
|
2017
Q2 | $668K | Buy |
+765
| New | +$627K | ﹤0.01% | 4709 |
|
|
2017
Q1 | – | Sell |
-102
| Closed | -$67.2K | – | 7938 |
|
|
2016
Q4 | $74K | Sell |
102
-94
| -48% | -$65K | ﹤0.01% | 6778 |
|
|
2016
Q3 | $144K | Sell |
196
-237
| -55% | -$192K | ﹤0.01% | 6497 |
|
|
2016
Q2 | $360K | Buy |
433
+81
| +23% | +$75.3K | ﹤0.01% | 4954 |
|
|
2016
Q1 | $291K | Buy |
352
+117
| +50% | +$91.9K | ﹤0.01% | 5134 |
|
|
2015
Q4 | $265K | Buy |
235
+199
| +553% | +$232K | ﹤0.01% | 5405 |
|
|
2015
Q3 | $30K | Sell |
36
-49
| -58% | -$71K | ﹤0.01% | 7921 |
|
|
2015
Q2 | $151K | Sell |
85
-209
| -71% | -$266K | ﹤0.01% | 6653 |
|
|
2015
Q1 | $353K | Sell |
294
-388
| -57% | -$454K | ﹤0.01% | 5425 |
|
|
2014
Q4 | $772K | Buy |
682
+507
| +290% | +$520K | ﹤0.01% | 4107 |
|
|
2014
Q3 | $176K | Buy |
175
+72
| +70% | +$81.3K | ﹤0.01% | 5855 |
|
|
2014
Q2 | $135K | Buy |
+103
| New | +$124K | ﹤0.01% | 5958 |
|
|
2014
Q1 | – | Sell |
-19
| Closed | -$24.7K | – | 7987 |
|
|
2013
Q4 | $22K | Buy |
19
+5
| +36% | +$6.89K | ﹤0.01% | 6410 |
|
|
2013
Q3 | $17K | Sell |
14
-18
| -56% | -$12.2K | ﹤0.01% | 6306 |
|
|
2013
Q2 | $13K | Buy |
+32
| New | +$13.6K | ﹤0.01% | 6173 |
|
Other funds holding RMTI
VCM
VFT
WANY
Citadel Advisors's RMTI Position: Q1 2026 in Review
Citadel Advisors sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 8,189 shares — an estimated $81.6K sold.
Citadel Advisors first reported a position in RMTI in Q2 2013 and held it in 41 quarters. The position peaked at $772K in Q4 2014. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Citadel Advisors reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 8,189 Rockwell Medical shares in Q1 2026, an estimated $81.6K.
- Citadel Advisors first reported a position in Rockwell Medical in Q2 2013 and held it in 41 quarters.
- Citadel Advisors's Rockwell Medical position peaked at $772K in Q4 2014.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.